November 05, 2026
| Steve Scherer
Asia, Europe, Latin America, Middle East, North America, Oceania
Drugmakers secured experimental treatments, expanded biosimilar portfolios and renegotiated royalty obligations, while life-sciences companies acquired technology and resolved patent disputes. Elsewhere, licensing provided...(read more)